Huamei Wei

guangxi clinical medical research center of hepatobiliary disease

H指数:15

被引数:794

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CCAT1 Enhances NK Cells‐Mediated Antitumor Immunity in Hepatocellular Carcinoma

<scp>CCAT1</scp> 增强 <scp>NK</scp> 细胞介导的肝癌抗肿瘤免疫

Immunology

IF5

2026-10-190

PRE

LINC02709 facilitates hepatocellular carcinoma metastasis by increasing stem cell-like properties and suppressing Kupffer cell phagocytosis

LINC02709通过增强干细胞样特性并抑制库普弗细胞吞噬作用促进肝细胞癌转移

Cell Death Discovery

IF7

2026-08-120

Diagnostic performance of a biotin-labeled 4D1 sandwich ELISA for serum antigen detection in talaromycosis

生物素标记的4D1夹心ELISA法在暗色丝孢霉病血清抗原检测中的诊断性能

PLoS Neglected Tropical Diseases

IF3.4

2026-05-010

Fluconazole tolerance is associated with altered extracellular vesicle-mediated epithelial immune responses in Candida albicans

氟康唑耐受性与白色念珠菌中细胞外囊泡介导的上皮免疫反应改变相关

Frontiers in Microbiology

IF4.5

2026-04-280

The iron-responsive transcription factor HapX drives iron starvation adaptation and virulence in Talaromyces marneffei

铁应答转录因子HapX驱动马尔尼菲青霉的铁饥饿适应和毒力

Current Research in Microbial Sciences

IF5.8

2026-04-160

OAAI

m6A-Methylated NUTM2B-AS1 Promotes Hepatocellular Carcinoma Stemness Feature via Epigenetically Activating BMPR1A Transcription

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2024-12-010

OAAI

Hsa_circ_0000092 up-regulates IL24 by SMC1A to induce macrophages M2 polarization

HELIYON

IF3.6

2024-09-010

OAAI

METTL3 and METTL14-mediated N6-methyladenosine modification of SREBF2-AS1 facilitates hepatocellular carcinoma progression and sorafenib resistance through DNA demethylation of SREBF2

METTL3和METTL14-mediated N6-methyladenosine修饰SREBF2-AS1通过SREBF2的DNA去甲基化促进肝细胞癌进展和索拉非尼耐药

SCIENTIFIC REPORTS

IF3.9

2024-03-145

OAAI

LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2024-03-012

OAAI

m6A modification of AC026356.1 facilitates hepatocellular carcinoma progression by regulating the IGF2BP1-IL11 axis

SCIENTIFIC REPORTS

IF3.9

2023-11-056

OAAI

N6-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2023-11-013

OAAI

N6-Methyladenosine-Modified ATP8B1-AS1 Exerts Oncogenic Roles in Hepatocellular Carcinoma via Epigenetically Activating MYC

N6-Methyladenosine-Modified ATP8B1-AS1通过表观遗传激活MYC在肝细胞癌中发挥致癌作用

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2023-09-013

OAAI

LncRNA MEG3 Inhibits Tumor Progression by Modulating Macrophage Phenotypic Polarization via miR-145-5p/DAB2 Axis in Hepatocellular Carcinoma

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2023-07-0115

OAAI

Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1α/VEGF signaling

CELL DEATH & DISEASE

IF9.6

2022-02-0262

OAAI

Long non-coding RNA HOMER3-AS1 drives hepatocellular carcinoma progression via modulating the behaviors of both tumor cells and macrophages

CELL DEATH & DISEASE

IF9.6

2021-11-2321

OAAI

ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis

FRONTIERS IN ONCOLOGY

IF3.3

2021-10-1821

OAAI

M2 macrophage-derived extracellular vesicles facilitate CD8+T cell exhaustion in hepatocellular carcinoma via the miR-21-5p/YOD1/YAP/β-catenin pathway

M2巨噬细胞衍生的细胞外囊泡通过miR-21-5p/YOD1/YAP/β-catenin途径促进肝癌CD8 T细胞耗竭

CELL DEATH DISCOVERY

IF7

2021-07-1665

OAAI

IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism

IGF2BP2通过m6A-FEN1-Dependent机制促进肝癌生长

FRONTIERS IN ONCOLOGY

IF3.3

2020-11-02112

OAAI

lncRNA MAGI2-AS3 Prevents the Development of HCC via Recruiting KDM1A and Promoting H3K4me2 Demethylation of the RACGAP1 Promoter

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2019-12-0143

OAAI

Long noncoding RNA HAGLROS promotes cell proliferation, inhibits apoptosis and enhances autophagy via regulating miR-5095/ATG12 axis in hepatocellular carcinoma cells

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2019-08-0160

PREAI

Huamei Wei

个人简介

教育背景

工作经历

荣誉奖项

研究方向